Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Methotrexate/mycophenolate-mofetil

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yang T-T, et al. Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy. Frontiers in Immunology 13: 30 Aug 2022. Available from: URL: http://doi.org/10.3389/fimmu.2022.934442 Yang T-T, et al. Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy. Frontiers in Immunology 13: 30 Aug 2022. Available from: URL: http://​doi.​org/​10.​3389/​fimmu.​2022.​934442
Metadaten
Titel
Methotrexate/mycophenolate-mofetil
Lack of efficacy: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33874-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Clopidogrel

Case report

Diazoxide

Case report

Multiple drugs

Case report

Osimertinib